Publications by authors named "Jeffrey Pu"

Claim this Profile
E
Efficacy of Total-Body Irradiation-based Intensified Myeloablative Regimens for Acute Leukemia-An International Collaborative Study.
Yasuyuki Arai, Ruta Brazauskas, Naya He, A Samer Al-Homsi, Saurabh Chhabra, Jeffrey J Pu

EJHaem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Pediatric myeloid neoplasms: new insights into diagnosis, prognosis, and treatment.
Viviane Lamim Lovatel, Jeffrey J Pu, Teresa de Souza Fernandez

Front Pediatr· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma.
Jeffrey J Pu, Kristin N Berger, Chunlei Zheng, Nhan Do, David F Claxton

Front Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Race and Ethnicity on Outcomes After Umbilical Cord Blood Transplantation.
Karen Ballen, Tao Wang, Naya He, Jennifer M Knight, Sanghee Hong, Jeffrey J Pu

Transplant Cell Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Checkpoint inhibition in hematologic malignancies.
Jeffrey J Pu, Joseph J Drabick, Susan E Prockop

Front Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis.
Roni Tamari, Donal P McLornan, Kwang Woo Ahn, Noel Estrada-Merly, Juan Carlos Hernández-Boluda, Jeffrey J Pu

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia cells and MSC-derived exosomes inhibiting transformation in myelodysplastic syndrome.
Xiaoli Liu, Fanggang Ren, Shuo Li, Na Zhang, Jeffrey J Pu

Discov Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impacts of total body irradiation on umbilical cord blood hematopoietic stem cell transplantation.
Hao Wang, Kristin N Berger, Elizabeth L Miller, Wei Fu, Larisa Broglie, Jeffrey J Pu

Ther Adv Hematol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel agents and evolving strategies in myelofibrotive neoplasm: an update from 2022 ASH annual conference.
Andrew Wang, James Liu, Jeffrey J Pu

J Hematol Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of CD70-specific CAR T cells targeting acute myeloid leukemia.
Gongqiang Wu, Shanshan Guo, Qian Luo, Xiaoxia Wang, Wenhai Deng, Jeffrey J Pu

Front Immunol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma.
Francis R LeBlanc, Zainul S Hasanali, August Stuart, Sara Shimko, Kamal Sharma, Jeffrey J Pu, Stephen E Spurgeon

Oncotarget· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunocompetent Patient With Primary Bone Marrow Hodgkin Lymphoma.
Armaan Dhaliwal, Vanessa F Eller, Jeffrey J Pu

J Med Cases· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen.
Meghan C Thompson, Rosemary A Harrup, Catherine C Coombs, Lindsey E Roeker, Jeffrey J Pu

Blood Adv· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of adjuvant chemotherapy in the management of acute promyelocytic leukemia differentiation syndrome.
Dominic LaBella, Samuel Regan, Heiko Konig, Daniel N Egan, Neil A Bailey, Jeffrey J Pu

Front Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mantle cell lymphoma management trends and novel agents: where are we going?
Jeffrey J Pu, Malvi Savani, Nick Huang, Elliot M Epner

Ther Adv Hematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.
Lindsey E Roeker, Toby A Eyre, Meghan C Thompson, Nicole Lamanna, Alexander R Coltoff, Jeffrey Pu

Blood· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD70-targeting CAR-T cells have potential activity against CD19-negative B-cell Lymphoma.
Wenhai Deng, Panpan Chen, Wen Lei, Yang Xu, Nengwen Xu, Jeffrey J Pu

Cancer Commun (Lond)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIGN spatiotemporally regulates the spindle assembly checkpoint proteins in leukemia transformation and progression.
Emmanuel K Teye, Shasha Lu, Fangyuan Chen, Wenrui Yang, Thomas Abraham, Jeffrey J Pu

Sci Rep· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3Kδ inhibitor therapy.
Anthony R Mato, Nilanjan Ghosh, Stephen J Schuster, Nicole Lamanna, John M Pagel, Jeffrey J Pu

Blood· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel agents and regimens for hematological malignancies: recent updates from 2020 ASH annual meeting.
Jing-Zhou Hou, Jing Christine Ye, Jeffrey J Pu, Hongtao Liu, Wei Ding

J Hematol Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resolution of Chronic Immune Thrombocytopenia Purpura after Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma.
Prashanth A Kumar, Ali Wazir, Jeffrey J Pu

J Med Cases· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study.
Antonio Cuneo, Anthony R Mato, Gian Matteo Rigolin, Alfonso Piciocchi, Massimo Gentile, Jeffrey J Pu

Cancer Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative Polyadenylation: a new frontier in post transcriptional regulation.
Fanggang Ren, Na Zhang, Lan Zhang, Eric Miller, Jeffrey J Pu

Biomark Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of COVID-19 in patients with CLL: a multicenter international experience.
Anthony R Mato, Lindsey E Roeker, Nicole Lamanna, John N Allan, Lori Leslie, Jeffrey Pu

Blood· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy.
Chaitra Ujjani, Anthony Mato, Brian T Hill, John N Allan, Frederick Lansigan, Jeffrey Pu

Blood Lymphat Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis